Protection against Streptococcus equi infection by monoclonal antibodies against an M-like protein.

This research article explores the protection offered against Streptococcus equi infection by using monoclonal antibodies (mAbs) against an M-like protein. The study identified two specific mAbs, 1D10 and 2A6, capable of providing significant protection against a lethal dose of the bacteria.

Research Methodology

• The researchers developed a passive transfer assay in mice as a mode of identifying mAbs which could provide protection against Streptococcus equi, a bacterium causing equine strangles, an infectious, contagious disease in horses.
• The assay used serum antibodies harvested from horses which were recovering from strangles. These antibodies were then introduced to mice.
• They also applied a preparation of an M-like protein, extracted from S. equi, on the mice. They observed it provided 80% protection to the mice against the infection.

Findings

• The team assessed a number of mouse mAbs that were directed against a preparation of M-like protein for their protective ability against a lethal dose of the bacteria.
• Two mAbs, designated 1D10 and 2A6, were found to be highly protective.
• Through a competitive enzyme immunoassay, it was shown that these antibodies recognized different epitopes or antigen binding sites in the preparation.
• Further examination of the dose-response curve for mAb 1D10 and 2A6 indicated that optimal protection levels were achieved with either 1 mg of 1D10 or 2A6, or a combination of 0.5 mg of 1D10 and 0.5 mg of 2A6.

Additional Observations and Inferences

• The immunological reactivity of mAbs 1D10 and 2A6 with the M-like protein preparation revealed that the antigens they recognized were similar in size to some of the antigens recognized by the antibodies from the convalescent horse serum.
• This might suggest that these antibodies target the same antigens that are recognized by the immune system during natural infection, potentially making them efficacious therapeutic options.
• The role of immunoglobulin isotype, a class of antibody that differs in their type of heavy chain, in providing protection was also discussed as a topic of further study. Isotype may play a role in the specificity and overall effectiveness of the targeted immune response.

Significance of Research

• This study contributes to the ongoing efforts in developing effective antibody-based therapies against bacterial infections, specifically Streptococcus equi. It provides insight into how specific mAbs could potentially be used to guard against detrimental bacterial infections in not only horses, but potentially other animals or even humans.
• The results could be instrumental in the development of targeted vaccinations and therapies by aiding our understanding of how these antibodies interact with their specific antigens.